193 related articles for article (PubMed ID: 2868983)
1. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology.
Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M
Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473
[TBL] [Abstract][Full Text] [Related]
3. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
[No Abstract] [Full Text] [Related]
4. Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.
Albus M; Naber D; Müller-Spahn F; Douillet P; Reinertshofer T; Ackenheil M
Biol Psychiatry; 1985 Oct; 20(10):1082-9. PubMed ID: 2864087
[TBL] [Abstract][Full Text] [Related]
5. [Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment].
Wolf MA; Bailly L; Diener JM; Martinet JP; Peretti S; Garneau Y
Encephale; 1991; 17(4):255-61. PubMed ID: 1683626
[TBL] [Abstract][Full Text] [Related]
6. Lateral ventricular size, psychopathology, and medication response in the psychoses.
Luchins DJ; Lewine RR; Meltzer HY
Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730
[TBL] [Abstract][Full Text] [Related]
7. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
Faraone SV; Brown WA; Laughren TP
J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
[No Abstract] [Full Text] [Related]
9. Suspension of neuroleptic therapy in acute schizophrenia.
Kuhs H; Eikelmann B
Pharmacopsychiatry; 1988 Jul; 21(4):197-202. PubMed ID: 2905064
[TBL] [Abstract][Full Text] [Related]
10. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
11. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Meltzer HY; Sommers AA; Luchins DJ
J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
Singh H; Hunt JI; Vitiello B; Simpson GM
J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
[TBL] [Abstract][Full Text] [Related]
13. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse].
Woggon B; Bickel P; Schnyder B
Int Pharmacopsychiatry; 1979; 14(5):278-93. PubMed ID: 43849
[TBL] [Abstract][Full Text] [Related]
14. [Incidence of the deficit form in refractory schizophrenia].
Samuelian JC
Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
[TBL] [Abstract][Full Text] [Related]
15. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
[TBL] [Abstract][Full Text] [Related]
16. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
Bralet MC; Yon V; Loas G; Noisette C
Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
[TBL] [Abstract][Full Text] [Related]
17. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
Yamagami S; Soejima K
Drugs Exp Clin Res; 1989; 15(4):171-6. PubMed ID: 2570687
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients.
Albus M; Botschev C; Müller-Spahn F; Naber D; Münch U; Ackenheil M
Pharmacopsychiatry; 1986 May; 19(3):101-5. PubMed ID: 3725889
[TBL] [Abstract][Full Text] [Related]
19. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
